Cookies on VetMed Resource

Like most websites we use cookies. This is to ensure that we give you the best experience possible.

 

Continuing to use www.cabi.org  means you agree to our use of cookies. If you would like to, you can learn more about the cookies we use.

Sign up to receive our Veterinary & Animal Sciences e-newsletter, book alerts and offers direct to your inbox.

Results per page:

Search results

Abstract

Objectives: Deslorelin 4.7 mg and melatonin 18 mg subcutaneous implants were studied in purebred male and female cats, via questionnaires sent to French cat breeders, to assess breed, age, duration of the contraceptive effect, fertility after use, changes in behaviour and side effects. Methods:...

Author(s)
Furthner, E.; Roos, J.; Niewiadomska, Z.; Maenhoudt, C.; Alain, F.
Publisher
Sage Publications, Thousand Oaks, USA
Citation
Journal of Feline Medicine and Surgery, 2020, 22, 10, pp 984-992
Abstract

Deslorelin implants have been used to produce a reversible sterilization in several species. In cats, the prolonged duration (12-15 months in tomcats and 18-22 months in queen) is often too much for cat breeders who request early implant removal. The interval between implant removal and resumption...

Author(s)
Ferré-Dolcet, L.; Carniello, L.; Ferro, S.; Cattai, A.; Romagnoli, S.; Mollo, A.
Publisher
MDPI AG, Basel, Switzerland
Citation
Animals, 2020, 10, 9,
Abstract

Effect of a GnRH-agonist (deslorelin) was studied on reproductive function and ovarian luteinizing hormone receptor (LHR) and follicle stimulating hormone receptor (FSHR) expression in prepubertal female cats that were either implanted with 4.7-mg deslorelin (implanted: n=6) or not (controls: n=18) ...

Author(s)
Mehl, N. S.; Srisuwatanasagul, S.; Swangchan-Uthai, T.; Sirivaidyapong, S.; Khalid, M.
Publisher
Elsevier, New York, USA
Citation
Theriogenology, 2017, 87, pp 250-258
Abstract

Objectives: The aim of the study was to evaluate the efficacy of a 4.7 mg deslorelin implant in tom cats. Methods: Nine mature male cats were included in the deslorelin group and five cats in the control group. Before the study started, all cats were confirmed to have distinct sexually dimorphic...

Author(s)
Gültİken, N.; Aslan, S.; Ay, S. S.; Gülbahar, M. Y.; Thuróczy, J.; Koldaș, E.; Kaya, D.; Fındık, M.; Schäfer-Somİ, S.
Publisher
Sage Publications, Thousand Oaks, USA
Citation
Journal of Feline Medicine and Surgery, 2017, 19, 2, pp 123-131
Abstract

Rationale: Deslorelin (Suprelorin®; Virbac) is a gonadotropin-releasing hormone (GnRH) agonist licensed in select countries for the long-term suppression of fertility in adult male dogs and male ferrets. This article summarizes studies investigating the use of deslorelin implants for the long-term...

Author(s)
Fontaine, C.
Publisher
Sage Publications, Thousand Oaks, USA
Citation
Journal of Feline Medicine and Surgery, 2015, 17, 9, pp 766-771
Abstract

Objectives: Gonadotropin-releasing hormone (GnRH) agonists like deslorelin are being increasingly used in tom cats for their efficacy in controlling reproductive behaviour and fertility. Deslorelin implants have been widely available in Europe since 2008. Little, if anything, is known about the...

Author(s)
Romagnoli, S.; Baldan, A.; Righetti, C.; Milani, C.; Mollo, A.; Stelletta, C.
Publisher
Sage Publications, Thousand Oaks, USA
Citation
Journal of Feline Medicine and Surgery, 2017, 19, 2, pp 194-199
Abstract

Objectives: The objective of this study was to assess duration of efficacy, side effects and return to fertility following use of the 9.4 mg deslorelin implant (Suprelorin 12; Virbac) in cats, and test whether efficacy and duration of action are influenced by implantation site (interscapular vs...

Author(s)
Romagnoli, S.; Baldan, A.; Ferro, S.; Righetti, C.; Scenna, L.; Gabai, G.; Badon, T.; Fontaine, C.; Mollo, A.; Stelletta, C.; Milani, C.
Publisher
Sage Publications, Thousand Oaks, USA
Citation
Journal of Feline Medicine and Surgery, 2019, 21, 6, pp 507-519
Abstract

GnRH-agonist implants are currently marketed in Europe for use in male dogs but their off label use in female dogs, cats as well as other wild or semidomesticated animals is becoming increasingly popular. Implanted females frequently show a fertile heat after treatment, but the ensuing pregnancy...

Author(s)
Cecchetto, M.; Gelli, D.; Ferré-Dolcet, L.; Martin, A.; Falomo, M. E.; Romagnoli, S.
Publisher
Elsevier, New York, USA
Citation
Journal of Exotic Pet Medicine, 2019, 29, pp 98-100
Abstract

Objectives: The purpose of this study was to assess efficacy of deslorelin, a gonadotropin-releasing hormone (GnRH) agonist marketed in Europe for the control of male dog reproduction, for the postponement of puberty in queens. Methods: Nine prepubertal queens aged 3-9 months were selected for this ...

Author(s)
Cecchetto, M.; Salata, P.; Baldan, A.; Milani, C.; Mollo, A.; Fontaine, C.; Sontas, H.; Gelli, D.; Benedictis, G. de; Stelletta, C.; Romagnoli, S.
Publisher
Sage Publications, Thousand Oaks, USA
Citation
Journal of Feline Medicine and Surgery, 2017, 19, 12, pp 1224-1230
Abstract

Ring-tailed lemurs (Lemur catta) are popular exhibit animals in zoos. During the breeding season, males may fight and this can result in serious wounds and/or escapes. The hormonal contraceptive deslorelin, a GnRH-agonist, has been used in different species to suppress reproduction. This...

Author(s)
Annaïs, C.; Oriol, T. P.; Maria, S. A.; Laura, M.; Dolores, C. M.; Cati, G.; Miguel, C.; Manel, L. B.
Publisher
European Association of Zoos and Aquaria (EAZA), Amsterdam, Netherlands
Citation
Journal of Zoo and Aquarium Research, 2018, 6, 2, pp 37-40

Refine Results

Sort Order
Author
Geographical Location
Item Type
Language
Organisms
Subject Topics